Starfire Investment Advisers’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$38K Hold
6,879
0.02% 156
2020
Q1
$36K Buy
6,879
+2,000
+41% +$15.1K 0.02% 147
2019
Q4
$30K Hold
4,879
0.01% 172
2019
Q3
$15K Hold
4,879
0.01% 172
2019
Q2
$20K Buy
4,879
+750
+18% +$3.14K 0.01% 161
2019
Q1
$15K Hold
4,129
0.01% 158
2018
Q4
$12K Buy
4,129
+2,000
+94% +$8.56K 0.01% 142
2018
Q3
$11K Hold
2,129
0.01% 130
2018
Q2
$9K Hold
2,129
﹤0.01% 137
2018
Q1
$8K Buy
+2,129
New +$9.39K ﹤0.01% 137
2017
Q4
Sell
-2,129
Closed -$10K 156
2017
Q3
$10K Hold
2,129
0.01% 119
2017
Q2
$13K Hold
2,129
0.01% 123
2017
Q1
$11.5K Hold
2,129
0.01% 148
2016
Q4
$12.3K Hold
2,129
0.01% 145
2016
Q3
$15.3K Hold
2,129
0.01% 143
2016
Q2
$18.5K Buy
+2,129
New +$20.4K 0.01% 140

Other funds holding CATX

Starfire Investment Advisers's CATX Position: Q2 2020 in Review

Starfire Investment Advisers held its Perspective Therapeutics (CATX) position steady in Q2 2020 at 6,879 shares worth $38K. The position accounts for 0.02% of the portfolio, ranked #156.

Starfire Investment Advisers first reported a position in CATX in Q2 2016 and has held it in 16 quarters since. 38 funds tracked by Wall St. Rank hold CATX as of Q2 2020.

  • Starfire Investment Advisers held 6,879 shares of Perspective Therapeutics worth $38K as of Q2 2020.
  • Starfire Investment Advisers left its Perspective Therapeutics share count unchanged in Q2 2020.
  • Perspective Therapeutics made up 0.02% of Starfire Investment Advisers's portfolio in Q2 2020, its #156 holding.
  • Starfire Investment Advisers first reported a position in Perspective Therapeutics in Q2 2016 and has held it in 16 quarters since.
  • 38 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2020.

Based on Starfire Investment Advisers's 13F filing for Q2 2020, filed 9 Jul 2020.